View drug registration information details.
Items | Registration information |
ID | 532 |
No | 532 |
Brand Name | KADCYLA 100 MG |
Ingredients | TRASTUZUMAB EMTANSINE 106MG |
Dosage Form | POWDER FOR INFUSION |
Primary Packaging | Vial |
Storage | STORE AT 2-8 C |
Shelf Life | 4 YEARS |
Pack Size | 1 VIAL/BOX |
Dispensing Category | Prescription only |
ATC Classification | XX |
Pharmaceutical Class | ANTINEOPLASTICS |
Indications | METASTATIC BREAST CANCER |
Contraindications | HYPERSENSITIVITY |
Side Effects | HEMORRHAGE, THROMBOCYTOPENIA, ANEMIA, DIARRHEA, NAUSEA, VOMITING, DRY MOUTH, ABDOMINAL PAIN, STOMATITIS FATIQUE, PYREXIA, ASTHENIA, CHILLS |
Unit Price | XXXX |
EDL |
No |
Description | WHITE TO OFF WHITE LYOPHILIZED CAKE, PRACTICALLY FREE FROM PARTICLES |
Note | |
License Owner | DKSH LAOS COMPANY LIMITED |
Manufacturer | F. HOFFMANN - LA ROCHE LTD. |
Country | SWITZERLAND |
Import Registration No | 62892 01 |
Import Registration Date | 2013-05-02 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2021-12-03 |
FDD Registration No | 08 I 4774/19 |
FDD Registration Date | 2022-07-22 |
Expiry Date | 2025-07-21 |
Back to drug list
|